chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within hours following the shot I started convulsing and shaking. I had severe tingles all over my body and weakness. This went on for days. I notified my doctor and she said to monitor for the inability to walk or move my limbs. I never lost complete feeling of my body parts. 2 months later and I still have tingling all over my body. I've had blood work, eye exam and MRI. I've had appointments with doctors-including radiologists and neurologists.
Pt presented to clinic to start Moderna vaccine series.  Pt did not disclose that she had originally started the Pfizer vaccine series in February and had received one dose at that time.  Pt given first dose of Moderna vaccine.  When pt presented for second dose of Moderna vaccine, the original Pfizer vaccine was discovered.
This spontaneous prospective pregnancy report was received from a nurse and refers to a female patient of unknown age. The patient's medical history, concurrent conditions, drug reactions and allergies were not reported. On 07-JAN-2015, the patient was subcutaneously vaccinated with M-M-R II (dose, anatomical location, lot# and exp.date were not reported) because MMRII titers, which were drawn on an unspecified date, were negative. It was unknown if and when the patient received M-M-R II in the past. The patient performed a home pregnancy test on an unspecified date, results were not reported. The patient found that she was pregnant on 09-JAN-2015. The date of last menstrual period and the estimated delivery date were unknown. The outcome of the event was unknown. The relatedness between vaccination with M-M-R II and negative MMRII titers was not reported. Additional information has been requested.
This case was reported by a other health professional via sales rep and described the occurrence of swelling arm in a patient who received BEXSERO for prophylaxis. On 3rd August 2018, the patient received BEXSERO. On an unknown date, 10 days after receiving BEXSERO, the patient experienced swelling arm. On an unknown date, the outcome of the swelling arm was unknown. It was unknown if the reporter considered the swelling arm to be related to BEXSERO. Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that he received this report late in the day on Friday, 3rd August 2018. The reporter noted that patient received BEXSERO and on day 10 after administration experienced a swollen arm.
3 3/4 x 2 1/4 x 2 3/4 induration. Reaction at injection site of PEDIARIX on left thigh IM. Soak in Epsom salt.
pt recv vax 6MAR96 & 10MAR97 pt devel chickenpox;
got the flu every time; Initial information was received on 18-Nov-2020 regarding an unsolicited valid non-serious case from a social media via consumer or non-health care professional.  This case involves a male patient (age unspecified) who experienced flu (influenza), while he received INFLUENZA VACCINE.  Medical history, medical treatment, concomitant medication and family history were not provided. It was reported that, patient got flu every time he got flu shot.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number and expiry date not reported] via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious flu (influenza), (unknown latency) following the administration of INFLUENZA VACCINE.   Details of laboratory data not reported.  It was not reported if the patient received any corrective treatment.   At the time of reporting, the event outcome reported as unknown for influenza.
Patient got third vaccine a full dose; This spontaneous case was reported by a consumer and describes the occurrence of INCORRECT DOSE ADMINISTERED (Patient got third vaccine a full dose) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066021A) for COVID-19 vaccination.     The patient's past medical history included Fibromyalgia. Concurrent medical conditions included Osteoporosis, Arthritis (arthritis different types) and Blood pressure high (high blood pressure controlled). Concomitant products included LISINOPRIL, ATORVASTATIN, DESVENLAFAXINE, CLONAZEPAM and METOPROLOL for an unknown indication.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INCORRECT DOSE ADMINISTERED (Patient got third vaccine a full dose). At the time of the report, INCORRECT DOSE ADMINISTERED (Patient got third vaccine a full dose) had resolved.            Patient also uses Diuretic , Inhaler, Cortisone injections as needed .Patient received full dose of third vaccine than the half dose .  Patient received all three vaccines in upper left arm.
developed an all-over body rash about 9 days later; The rash was a combination of red rash and hives; red rash; irritation in the throat and esophagus; irritation in the throat and esophagus; This is a spontaneous report received from a contactable consumer. A 58-year-old male patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. On an unspecified date 9 days after the vaccine, the patient experienced an all-over body rash. The rash started under the arm and worked its way across his torso and back, neck, face, buttocks, back of knees, and groin. The rash was a combination of red rash and hives. The patient also had some irritation in the throat and esophagus on an unspecified date. The patient had ruled out everything else including food, soaps, etc and nothing had changed. The patient saw an allergist who believed that his reaction was due to his body building an antibody response to the vaccine. The allergist advised the patient wait two additional weeks before receiving dose 2 of BNT162B2. The outcomes of all-over body rash, red rash, hives, and irritation in throat and esophagus were unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
employee had the 1st dose and later had shingles; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of HERPES ZOSTER (employee had the 1st dose and later had shingles) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history provided).    On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (employee had the 1st dose and later had shingles). At the time of the report, HERPES ZOSTER (employee had the 1st dose and later had shingles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no concomitant medication provided no treatment taken; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events,   a causal relationship cannot be excluded.
Chest congestions; Trouble breathing; Coughing; Fever; A spontaneous report, was received from a consumer (patient's mother), regarding a 21 years-old male patient, unknown race and ethnicity, who was administered Moderna's COVID-19 vaccine (mRNA-1273), and experienced chest congestions (pulmonary congestion), trouble breathing  (dyspnea), fever (pyrexia), and coughing (cough).  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 14 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection.  On an unknown date in Jan 2021, the consumer reported that for three days, the patient from fever, trouble breathing, a lot of chest congestions, and coughing. After a few days, the patient was doing fine. No treatment information was reported.  Action taken with second dose of mRNA-1273 in response to the events was not reported.  The outcome of events, chest congestions, trouble breathing, fever, and coughing were recovered/resolved.; Reporter's Comments: There is not enough information to assess the events of chest congestions, trouble breathing and coughing as the onset dates for the events were not provided.  In addition, the patient's medical history is lacking.  However fever is  consistent with the known safety profile of the vaccine. Further information has been requested
Hives on chest and on the inside of the elbows; Chills; Sweats; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweats), URTICARIA (Hives on chest and on the inside of the elbows) and CHILLS (Chills) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced HYPERHIDROSIS (Sweats) and CHILLS (Chills). On 15-Feb-2021, the patient experienced URTICARIA (Hives on chest and on the inside of the elbows). On 17-Feb-2021, URTICARIA (Hives on chest and on the inside of the elbows) had resolved. At the time of the report, HYPERHIDROSIS (Sweats) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Pt received flu and pneumonia shot same day, reported arm pain on pneumonia arm. Contacted pt for more details, did not hear back.
A quality assurance analysis has revealed that this patient likely received an additional Shingrix vaccination above the recommended 2 (two) doses of the complete Zoster (Shingles) vaccination series, with the additional dose being given at her Primary Care Physician?s office.  In a good faith effort for full disclosure, it appears that due to a problem in the connection between our computer system and the vaccination registry, her Primary Care Physician would not have been aware that she had already started a Shingrix vaccination series elsewhere.
Bruise noted at injection site, approx 1 1/2" x 1". No swelling or redness, no fever. Rash like area below inj site, about 1" x 1". Not itchy or painful. Improved in 24 hours with cortisone cr to area.
The patient reported a bee allergy with previously epi use (not in the past 12 years). She was allowed to wait for 30 minutes after her injection. About 45 minutes after the injection she felt "heat" and a "metallic taste" in her mouth. She drove home via private vehicle and administered epi at home (approx 90 minutes after injection). She also took Benadryl (2 tablets). She did not seek medical care afterwards, but did call her doctor to inform her of the above. She proceeded with her second injection (06/11/2021) and noted a cough post injection (started day 2 after and continuing 3 months afterwards).
Sore arm, hard chills, malaise, shaking, rapid and shallow breathing x1 hour. Induration 7mm expanded to approximately 80mmx100mm, red, warm and tender to touch.
Received Moderna vaccine in left deltoid on 12/24/2020. Originally had injection site soreness lasting ~2-3 days which then 100% resolved. On 12/29/2020, developed tender, sore, left axillary lymph node. On 1/1/2020, woke with tenderness, soreness, erythema, warmth and induration localized to injection site on left deltoid.
I was out of town for work and on the morning of 8/24 @ 4am I woke up with severe chest pains and high pulse rate with major nerve pain in both legs and entire back. 911 was called and I was transported via ambulance the Clinic ED in city.  Arrived with Chest Pains, high pulse rate, legs and back pain. All heart enzymes were normal, CT and stress test was normal but had and abnormal ECG. Monitored me through out the day, could not find any reason for the pain or pulse rate. Was released that afternoon with a diagnosis of polyneuropathy of unknown cause and possible diabetes. Multiple providers examined me and said timing with the vaccine was just coincidence. I continue to have a high pulse rate with back and leg pain. If I get startled or move quickly, nerve pain shoots all through my body. Nobody has any explanation for it.
Hives by 8am on 7/22/22, followed by dizziness, shakiness, extreme nervous agitation by 9:30am.  Vaccine booster on 7/18/22, followed by a day of fever, aches, fatigue on 7/19.  Continued hydrating and felt mostly OK on 7/20, felt good on 7/21/22 - strong enough for 2 mile walk (normal would be 3-4 miles).  The nervous agitation on 7/22 was very disturbing - felt this same condition after my first booster shot but never at any other time in my life.  Very healthy otherwise.  Hives did not increase beyond what appeared in morning of 7/22 and nervous condition eased by noon but very fatigued afterwards.
out of the range of time for the second dose; Staph Infection in the nose; This spontaneous case was reported by a consumer and describes the occurrence of STAPHYLOCOCCAL INFECTION (Staph Infection in the nose) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced STAPHYLOCOCCAL INFECTION (Staph Infection in the nose) (seriousness criterion medically significant). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (out of the range of time for the second dose). On 01-Apr-2021, STAPHYLOCOCCAL INFECTION (Staph Infection in the nose) had resolved. At the time of the report, PRODUCT DOSE OMISSION ISSUE (out of the range of time for the second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided.  Treatment with anti-biotic therapy was provided by the patient pertained to the events experienced.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Information has been received from a nurse referring to a patient of unknown age and gender. No current or historical conditions were reported. On 09-APR-2015, the patient was vaccinated with VARIVAX (Merck), 0.5 ml, subcutaneous (lot # K007981 and expiration date 03-JUN-2015). The vaccine of VARIVAX (Merck) was post temperature excursion, which excursion was supported. No adverse effects noted. Additional information has been requested.
No addtional AE; HCP reporting that a patient received VAXNEUVANCE and after the injection was given, the syringe broke into two pieces while attempting to put the safety back on the needle. Additional AE/PQC were recorded, refer to case #02455865 for PQC details. No; after giving the injection; The spontaneous report was received from a medical assistant regarding a 6-month-old female patient. Information regarding medical history, concurrent conditions and concomitant medications was not reported.   On 21-AUG-2023, the patient was vaccinated with a dose of pneumococcal 15v conj vaccine (CRM197) (VAXNEUVANCE) at a dose of 0.5 ml  intramuscularly as vaccination (prophylaxis) (lot number X004289 and expiration date 10-DEC-2024 have verified to be valid) (no more vaccination details were provided). Then, the syringe broke into two pieces above the hub of the needle while attempting to put the safety on the needle after giving the injection (poor quality device used). Straight through "at the neck of the syringe, just above where the needle attaches" and the top of the syringe was broken off (type, brand, needle size and gauge: HTLSTREFA 25 g 1 inch) (syringe issue). No one was injured as a result of the breakage. Moreover, she reported that she was only able to send one syringe back, as the other syringe (information captured in # 2308USA007836) was thrown away after it broke. No further information or clarification was provided. No additional adverse event (AE) reported (no adverse event).
More sore than getting a flu shot; This case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in an unspecified number of patients who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the pain in arm to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were reported as follows: The age at vaccination was not reported. The reporter stated that arm soreness felt after Shingrix vaccine was more sore than getting a flu shot. The reporter consented to followup. This case has been linked with US2020203882 reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020203882:same reporter
C/o fever, chills, headache & stomach ache 1 day after receiving first dose
Short of breath; threw up; Chills; low fever; a little headache; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Short of breath), VOMITING (threw up), CHILLS (Chills), PYREXIA (low fever) and HEADACHE (a little headache) in a 56-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012F21A, 037A21B and 040A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Oct-2021 at 10:00 AM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Oct-2021 at 8:00 PM, the patient experienced DYSPNOEA (Short of breath), VOMITING (threw up), CHILLS (Chills), PYREXIA (low fever) and HEADACHE (a little headache). The patient was treated with POTASSIUM on 31-Oct-2021 for Adverse event, at a dose of UNK (little bit). At the time of the report, DYSPNOEA (Short of breath), VOMITING (threw up), CHILLS (Chills), PYREXIA (low fever) and HEADACHE (a little headache) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In October 2021, Heart rate: 80-90 (High) still high in the 80-90s. On 30-Oct-2021, Heart rate: 120 (High) having a fast heartrate of 120. On 31-Oct-2021, Heart rate: fine (normal) she was fine and to go home.         No concomitant medications were provided by the reporter.  Treatment: Patient received IV and a little bit of potassium at the ER Was a cause determined? Patient reports it was from the Moderna vaccine. Please try to obtain a timeline of symptoms including Cardiac Lab values (ECG, cardiac test, cardiac enzymes).
Client's mother stated when she called, that client received her shots on Thursday 3/2/06 PM and that evening became ill with flu-like symptoms and fever x 2 days. When daughter awoke on Saturday 3/4/06 AM, she showed her mother her R leg was swollen and red at the site of one of the injections. Mother called the pediatrician and he stated to watch the area and go to a clinic if it increased in size which mother did on 3/5/06 and was sent to ER. Client was given 1 dose IM Keflex and oral Keflex. Diagnosed with acute cellulitis or sterile abscess. 3/21/06 /// clinic supv.
No additional AE reported; GARDASIL 9 that had undergone temperature excursion on 12/10/2021 was administered to a patient on 1/18/2022; This spontaneous report was received from a certified medical assistant and refers to 13-year-old female patient. There was no information regarding patient's medical history, concurrent conditions and concomitant medications provided.  On 18-JAN-2022, the patient was vaccinated with improperly stored HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) in dose 0.5 milliliter (lot# 1687293 verified as valid with expiration date: 30-APR-2023) (dose number, frequency, route of administration and anatomical location were not provided) for prophylaxis. The aforementioned vaccine underwent a temperature excursion of 23 degrees Fahrenheit for 2.5 seconds (product storage error temperature too low) on 10-DEC-2021, before administration. There was no previous temperature excursion. It was unknown if digital data logger was involved. No additional adverse events were reported (no adverse event).  This is one of several reports received from the same reporter. ; Sender's Comments:  US-009507513-2203USA004292:
swollen lymphnodes in left ear to arm area Narrative:  employee went to PCP. They determined the employee had an ear infection and prescribed antibiotics
After the vaccine the patient 3 minutes after started coughing, became flushed, diaphoretic and had trouble breathing called 911 the paramedics were there immediately and took her to the ER in ambulance. The patient called later to say that they treated her for allergic reaction and she was ok.
All fine after injection other than soreness at injection site. After sleeping at 3:00am had terrible side effects with chills, nausea and diarrhea. Terrible headache that eventually turned into serious migraine.  Asked pharmacist, next morning if it was allowed to take an Imitrex injection for migraine after having vaccine.  Pharmacist said it was ok to take injection. Helped reduce migraine enough to be in bed resting the rest of that following day. Recovered and back to normal by next day the 25th. With Janssen vaccine concern now with cerebral clotting with severe headache as a sign, decided to report bad side effects and make sure I shouldn?t be having anything else checked for precaution.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. On 08-JAN-2015 the patient was vaccinated with ZOSTAVAX subcutaneous, expiry date: 19-DEC-2014 (dose, lot # not reported). On 08-JAN-2015 the patient received an expired dose of ZOSTAVAX. There were no known adverse effects. Additional information has been requested.
After the vaccine, I was achy and feverish for 12 -15 hours and then I was totally fine - I felt like I was hit by a car. I didn't have arm pain.  In July, I had a runny  nose and a fever and a massive headache and scratchy throat and it hurt to swallow and a cough that will not go away.  Wednesday - the 7th  - Urgent Care - on street in town. I took a COVID test and it was negative and they told me to take OTC to treat symptoms and that there wasn't anything I could do. I still have a nagging cough.
Urinary urgency and urethra burning, no infection. Bladder spasms and severe cramping.